Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
I
|
International Flavors & Fragrances Inc
DUS:IFF
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
XMUN:ME9
|
IT |
|
O
|
Occidental Petroleum Corp
LSE:0KAK
|
US |
|
Flowers Foods Inc
NYSE:FLO
|
US |
|
N
|
Nexon Co Ltd
F:7NX
|
JP |
|
Renasant Corp
NYSE:RNST
|
US |
|
U
|
United Rentals Inc
XMUN:UR3
|
US |
|
A
|
Avis Budget Group Inc
XMUN:CUCA
|
US |
|
Japan Tobacco Inc
F:JAT
|
JP |
|
Virgin Galactic Holdings Inc
F:0QL0
|
US |
|
A
|
Arizon RFID Technology Cayman Co Ltd
TWSE:6863
|
KY |
|
P
|
Porr AG
DUS:ABS2
|
AT |
|
K
|
Kadant Inc
F:KDA
|
US |
|
A
|
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
|
TH |
|
Nissan Chemical Corp
OTC:NNCHF
|
JP |
|
S
|
Societe BIC SA
OTC:BICEF
|
FR |
|
W
|
Westpac Banking Corp
F:WBC
|
AU |
Bankruptcy Probability
Rigel Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rigel Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
786.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rigel Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rigel Pharmaceuticals Inc has total debt of 15m USD. This includes both short-term (0 USD) and long-term (15m USD) debt.
You can find a full breakdown on its Balance Sheet.
